Our Recommendations
- WHO guidelines on meningitis diagnosis, treatment and care. Web Annex C. Evidence-to-Decision frameworks (2025)
- WHO guidelines on meningitis diagnosis, treatment and care. Web Annex B. Qualitative and economic evidence reports (2025)
- WHO guidelines on meningitis diagnosis, treatment and care. Web Annex A. Quantitative evidence reports (2025)
- Guidelines forPrevention and Management of Stroke (2019)
- Alzheimer's Disease International. The Global Voice on Dementia (2019)
New Publications
- WHO guidelines on meningitis diagnosis, treatment and care. Web Annex C. Evidence-to-Decision frameworks (2025)
- WHO guidelines on meningitis diagnosis, treatment and care. Web Annex B. Qualitative and economic evidence reports (2025)
- WHO guidelines on meningitis diagnosis, treatment and care. Web Annex A. Quantitative evidence reports (2025)
- WHO guidelines on meningitis diagnosis, treatment and care (2025)
- Dementia in Latin America and the Caribbean: Prevalence, Incidence, Impact, and Trends over Time (2023)
Filter
229
Featured
Recommendations
19
New Publications
15
Language
Document type
No document type
203
Training Material
7
Guidelines
7
Fact sheets
4
Studies & Reports
3
Manuals
2
Strategic & Response Plan
2
Resource Platforms
1
Countries / Regions
Russia
23
Ukraine
18
Eastern Europe
14
Africa
12
Western and Central Europe
12
India
9
Global
5
Latin America and the Carribbean
4
Germany
3
Uganda
3
South Sudan
3
Nepal
2
Syria
2
Nigeria
2
Estonia
2
Congo, Democratic Republic of
2
Australia
1
China
1
Chile
1
Iran
1
USA
1
Asia
1
South–East Asia Region
1
Brazil
1
Authors & Publishers
Publication Years
Category
Public Health
16
Clinical Guidelines
14
Countries
8
Capacity Building
4
Women & Child Health
1
Key Resources
1
Epilepsies: diagnosis and management
recommended
Clinical guideline | Published: 11 January 2012 | nice.org.uk/guidance/cg137
Q10: For carers of people with dementia, does respite care when compared to care as usual, produce benefits/harm in the specified outcomes?
Q1: What are the effective maternal mental health interventions to prevent developmental problems in early infancy?
www.jogh.org • doi: 10.7189/jogh.02.020405 ~ December 2012 • Vol. 2 No. 2 • 020405
Neurology in Africa
recommended
The whole book has 50.3 MB!!!!
To download chapter by chapter:
http://www.uib.no/cih/en/resources/neurology-in-africa
Africa is a vast continent and neurological disorders are a common cause of disability and death. This practical neurology textbook is specifically written for Sub-Saharan Africa....
Q4: For people with dementia with associated depression, do antidepressants when compared to placebo/comparator produce benefits/harm in the specified outcomes?
Q8. Should Anti-Epileptic Drug (AED) treatment be started after first unprovoked seizure in non-specialist health settings?
Q6: Can dementia be diagnosed at first or second level care by non-specialist health care providers? What should be the assessment process for the diagnosis of dementia?
Q5: What is the added advantage of doing an electroencephalography (EEG) in people with convulsive epilepsy in non- specialist settings in low and middle income countries?
BMC Medicine201210:107
https://doi.org/10.1186/1741-7015-10-107© Katchanov and Birbeck; licensee BioMed Central Ltd. 2012
Received: 10 July 2012Accepted: 24 September 2012Published: 24 September 2012
In 2011, the World Health Organization’s (WHO) mental health Gap Action Programme (mhGAP) r...
Q8: For people with dementia, what is the role of a medical review (including comorbid physical and mental conditions and medication use)?
Q2: For people with dementia, does memantine, when compared to placebo/comparator, produce benefits/harm in the specified outcomes in non-specialist health settings?
Q 7: For adults and children with convulsive epilepsy, which standard antiepileptic drugs (phenobarbital, phenytoin, carbamazepine, valproic acid) when compared to placebo/a comparator produce benefits/harm in the specified outcomes?
Paediatrics
Chapter I.2
Q11: 11a). In women with epilepsy, should antiepileptic therapy be prescribed as monotherapy or polytherapy to decrease the risk of fetal malformations?
11b). Does the use of folic acid preconceptually decrease the risk of foetal malformations in women with epilepsy?
11c). Do phenytoin, phenobarbi...
Цель: анализ уровня тревожности и тяжести депрессии у больных рассеянным склерозом. Материал и методы. Чтобы определить уровень депрессии и тревожности у больных ...
Q6: What is the added advantage of doing neuroimaging in people with convulsive epilepsy in non-specialist settings in low and middle income countries?
Q3: For behavioural and psychological symptoms in people with dementia, do following drugs, when compared to placebo/comparator, produce benefits/harm in the specified outcomes?
Lancet 2012; 380: 1193–1201
Series: Epilepsy 2
Q7: For people with dementia, who should be told of the diagnosis and how should the diagnosis be delivered?
